Biden to remark on Social Security, Medicare; strategy to end hunger in US includes more benefits

WASHINGTON (AP) — The Biden administration is laying out its plan to meet an ambitious goal of ending hunger in the U.S. by 2030, including expanding monthly benefits that help low-income Americans buy food.

Biden remarks on Social Security, Medicare; strategy to end hunger in US includes more benefits

Related:

Biden admin to propose nutrition labels on front of food packaging in push to improve health

Because people don’t know how to turn the product around to read labels?!

The Failed Serotonin Theory of Depression: A Marxist Analysis

By Carlos L. Garrido – Sep 9, 2022

A recent study published in the journal Molecular Psychiatry sent shockwaves across the scientific community and popular outlets as it disproved the predominant “serotonin hypothesis” of depression. In just two weeks since its publication it has been accessed by nearly half a million people and the subject of dozens of subsequent articles. The researchers analyzed a total of seventeen systematic reviews, meta-analyses, and other large studies focused on the following six tenets pertinent to the “serotonin hypothesis” of depression:

The Failed Serotonin Theory of Depression: A Marxist Analysis

New COVID Booster Approved From Final Study of Mice, Not Humans, But Using Only Animal Data Is a Needless Gamble

VERIFY: New COVID booster approved from final study of mice, not humans

According to documents on the CDC website, human tests of Moderna’s version of the new booster are still “ongoing.” Right now, there is only final evidence from “8-10 mice” per group.”

The FDA’s website shows for Pfizer the agency also relayed on the final study evidence from “8 mice.” But human trials are also ongoing. So far, the new boosters “showed a similar local reaction and systemic event profile.” That means side effects appear to be about the same including “mild to moderate injection site pain, fatigue, and muscle pain.”

“To advance the Omicron BA.4/BA.5 bivalent vaccine as rapidly as possible, regulators, including the FDA, WHO and EMA, have advised that our submissions be based on safety and immunogenicity data generated in adults with an Omicron BA.1 bivalent vaccine and supported by BA.4/BA.5 bivalent pre-clinical data and BA.4/BA.5 bivalent quality and manufacturing data. These packages follow a similar model to that provided to public health officials who evaluate seasonal flu vaccines each year. Moving forward, this approach may help address the pressing need for vaccines that provide a high level of protection against current and emerging variants of concern so that we can remain vigilant against this evolving virus. The FDA has authorized our Omicron BA.4/BA.5 bivalent vaccine based on clinical data generated in adults with an Omicron BA.1 bivalent vaccine, pre-clinical data with a BA.4/BA.5 bivalent vaccine and BA.4/BA.5 bivalent quality and manufacturing data. Pre-clinical data showed a booster dose of Pfizer and BioNTech’s Omicron BA.4/BA.5- bivalent vaccine generated a strong neutralizing antibody response against Omicron BA.1, BA.2 and BA.4/BA.5 variants, as well as the original wild-type strain. A clinical study investigating the safety, tolerability and immunogenicity of the Omicron BA.4/BA.5 bivalent vaccine in individuals 12 years of age and older is ongoing. Data will be shared with regulators when available. We are facing a virus with an exceptionally high mutation rate, which the nimble mRNA platform is well situated to address. Only the mRNA sequence requires updating to match emerging strains, and utilizing a bivalent vaccine aims to provide broader coverage against known and future COVID-19 variants of concern.”

Related:

Read More »

Nancy Pelosi Visit to Taiwan Backfired….Asia Pacific Wants China!

Sep 3, 2022 – The world is watching Taiwan and now a month after Nancy Pelosi’s visit to Taiwan we are starting to see Asia Pacific countries speak out for peace and hope there is no conflict. In today’s video I document how the US foreign policy is too emotional and lacks strategic direction, both of which will result in a more dangerous and chaotic world.

Nancy Pelosi Visit to Taiwan Backfired….Asia Pacific Wants China! via Cyrus Janssen

Cyrus brings up Paul Pelosi Jr but he doesn’t mention which mining companies that Jr invested in. A quick search shows which mining companies and that he was also involved with a few other companies.

Related:

Nancy Pelosi’s Son, A ‘Green Technology’ and Lithium Investor, Was An ‘Unnamed Guest’ On Her Taiwan Trip

Pfizer’s anti-COVID pill Paxlovid shows no benefit for younger adults

Pfizer’s anti-COVID pill Paxlovid shows no benefit for younger adults

The report’s authors found that Pfizer’s antiviral medication Paxlovid offered little to no benefit for younger adults. However, it did reduce the risk of hospitalization for high-risk seniors. Notably, supplementary material from the original study of Paxlovid in high-risk non-hospitalized adults with COVID-19 during the Delta wave had demonstrated benefits in those younger than 65, albeit the difference compared to the placebo was much less than in those 65 and older.

Among those over 65, there was a 73 percent decrease in the hospitalization rate and a 79 percent reduction in the risk of death. However, patients between the ages of 40 and 65 saw no benefit in taking the antiviral medication in either category, regardless of previous immunity status.

Another critical study from Hong Kong published in Lancet Infectious Diseases on the same day as the Israeli study but which went unmentioned in the press offered further evidence of Paxlovid’s limited therapeutic role. The authors reviewed their clinical experience with Paxlovid and Lagevrio, Merck’s antiviral pill, Molnupiravir, in hospitalized patients. They compared them to hospitalized patients who did not receive those medications during the horrific wave of infections that slammed into the semi-autonomous region in February and March.

The mortality risk reduction for Lagevrio was 52 percent, and for Paxlovid it was 66 percent. Those receiving antivirals had a lower risk of their disease progressing, but the drugs did not significantly impact their need for mechanical ventilation or ICU admission. The patients in the study averaged in age from mid-70s to early 80s.

Given the results of these studies, it bears mentioning that the Centers for Disease Control and Prevention (CDC) has recently estimated that approximately 95 percent of Americans aged 16 and older have some level of immunity against COVID-19.

Nebraska Mother, Daughter Face Abortion Charges After Facebook Shares Chats With Police

Digital rights advocates on Tuesday said an abortion case in Nebraska illustrates how powerful tech companies like Facebook could play a major role in prosecutions of people who self-manage abortions as more states ban the procedure, and called on the social media platform to reform its privacy policies to protect users.

Nebraska Mother, Daughter Face Abortion Charges After Facebook Shares Chats With Police

BUT WHY?! Kenya Has Zero Cases But U.S Pharmaceutical Firm To Start Vaccine Trial + WHO Issues Monkeypox Advisory to Kenya

Video via Wongel Zelalem

Tonix will test its monkeypox vaccine in Kenya next year, and no eyes on accelerated path at FDA

The study of Tonix Pharmaceuticals’ live virus vaccine will occur at Kenya Medical Research Institute, or KEMRI, in the East African country, the partners said Thursday. While Kenya has no reported cases of the virus that leads to painful lesions, the country is close to the Democratic Republic of the Congo, which had 163 cases as of July 27, according to a CDC tracker.

Tonix has been working on monkeypox and smallpox for close to a decade, Lederman said. The company’s vaccine, dubbed TNX-801, is traced back to a research collaboration with the Department of Cell Biology at the University of Alberta.

Related:

Read More »

Biden administration weighs declaring monkeypox a health emergency + Break Out the Condoms to Fight Monkeypox

Biden administration weighs declaring monkeypox a health emergency

Related:

Doctors treating monkeypox complain of ‘daunting’ paperwork, obstacles

D.C. shifts monkeypox vaccine policy to focus on first dose

Break Out the Condoms to Fight Monkeypox (archived if you can read behind the advertisements)*

But we should also remember that we have never vaccinated our way out of any pandemic. In the West, measles, scarlet fever, and other childhood diseases stopped killing kids decades before vaccines—our preferred tool of mass salvation—arrived in the late 1950s. Smallpox was similarly largely controlled by the turn of the 20th century through public health measures.

We need to stop subordinating people to the virus. A single approach of surveillance, isolation, contact tracing, and vaccination worked very well for smallpox, which relied exclusively on a human host, could be diagnosed at 10 paces, and was prevented with a single vaccination. But even that approach relied not only on tests and vaccines but also, most of all, on trust—to be tested and vaccinated. Candor is a prerequisite for trust.

*Just a little deception behind the headline. Still touting vaccines (Jynneos), as a solution, though! Just use condoms, for prevention, and prescribe antivirals (TPOXX), for treatment, if needed!

Baby Formula Crisis Requires Urgent Action to Address Shortage of Vital Nutrition & Price Gouging

Four corporations control 90% of the baby formula market in the United States, and as a national baby formula shortage drags on, it has impacted working-class families of color the most. We get an update from Democratic Congressmember Ro Khanna of California, who just wrote an open letter urging leaders of federal agencies such as the Food and Drug Administration to take bolder action to address the shortage. Khanna discusses efforts to increase production domestically and supplement the shortage with formula from other nations, and why he is calling for President Biden to go further and pass antitrust laws to reduce reliance on corporate monopolies for vital products. “Why is it that we are so dependent on one or two manufacturers in this country?” says Khanna. “This is a problem not just in baby formula.”

Baby Formula Crisis Requires Urgent Action to Address Shortage of Vital Nutrition & Price Gouging